Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nasacort in Chronic Non-Allergic Rhinitis
NCT00344942Phase 3Terminated
- Sponsor
- Sanofi
- Start
- Apr 2006
- Primary completion
- Apr 2007
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of triamcinolone acetonide in non-allergic rhinitis (NAR), sponsored by Sanofi. Started Apr 2006; status: terminated.
02
Drugs
triamcinolone acetonide
03
Conditions
non-allergic rhinitis (NAR)
Beyond the preview
Go deeper on NCT00344942.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00344942.